859199-06-7 Usage
General Description
3-[4-(Trifluoromethyl)phenyl]-1H-pyrazole is a chemical compound with the molecular formula C9H6F3N3. It belongs to the class of pyrazole derivatives and contains a trifluoromethyl group attached to a phenyl ring. 3-[4-(Trifluoromethyl)phenyl]-1H-pyrazole has shown potential as a building block in organic synthesis and pharmaceutical research. It has been used in the development of various pharmaceuticals due to its unique structural properties and potential biological activities. Additionally, 3-[4-(Trifluoromethyl)phenyl]-1H-pyrazole has also been studied for its potential applications in agrochemicals and material science.
Check Digit Verification of cas no
The CAS Registry Mumber 859199-06-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,9,1,9 and 9 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 859199-06:
(8*8)+(7*5)+(6*9)+(5*1)+(4*9)+(3*9)+(2*0)+(1*6)=227
227 % 10 = 7
So 859199-06-7 is a valid CAS Registry Number.
InChI:InChI=1/C7H7BrOS/c1-4-3-6(5(2)9)10-7(4)8/h3H,1-2H3
859199-06-7Relevant articles and documents
CYCLIC SULFAMIDE COMPOUNDS AND METHODS OF USING SAME
-
Page/Page column 305-306, (2018/09/21)
The present disclosure provides, in part, cyclic sulfamide compounds, and pharmaceutical compositions thereof, useful as modulators of Hepatitis B (HBV) core protein, and methods of treating Hepatitis B (HBV) infection.
ORGANIC COMPOUNDS
-
Page/Page column 38, (2010/08/05)
The invention relates to new isoxazofine compounds of formula (I), wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful in the control of parasites, in particular ectoparasites, in and on warmblooded animals.
PHENYL AND PYRIDYL COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES
-
Page/Page column 116, (2010/11/28)
The invention relates to compounds of structural formula (I): or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof, wherein R1, X1, X2, Y, Z, L, and n are defined herein. The compounds are useful a